Millipore acquiring Serologicals

Research product supplier SERO rose $7.83 (34%) to $31.15 on Tuesday after supply and service company MIL offered to acquire SERO's 44 million shares for $31.55 in cash, which values the deal at $1.4 billion. The price is a 35% premium to SERO's close of $23.32 on Monday. The companies said the deal would strengthen MIL's position in drug discovery products and services. SERO sells consumables and offers technologies and services for biological research, drug discovery and bioprocessing. ...